Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands

BACKGROUND: In the Netherlands, more than one million patients have type 2 diabetes (T2D), and approximately 36% of these patients have chronic kidney disease (CKD). Yearly medical costs related to T2D and CKD account for approximately €1.3 billion and €805 million, respectively. The FIDELIO-DKD tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Quist, Sara W., van Schoonhoven, Alexander V., Bakker, Stephan J. L., Pochopień, Michał, Postma, Maarten J., van Loon, Jeanni M. T., Paulissen, Jeroen H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685667/
https://www.ncbi.nlm.nih.gov/pubmed/38017448
http://dx.doi.org/10.1186/s12933-023-02053-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685667/
https://www.ncbi.nlm.nih.gov/pubmed/38017448
http://dx.doi.org/10.1186/s12933-023-02053-6

Ejemplares similares